Educational Session 1: Biomarker-guided Precision Therapy in Metastatic Breast Cancer
Session Details
Presentation numberED1-01
Moderator
Philippe Bedard, Princess Margaret Cancer Centre, Toronto, ON, Canada
Presentation numberED1-02
Actionable mutations in HR+/HER2- Disease
Maria Coakley, BC Cancer Vancouver, Vancouver, BC, Canada
Presentation numberED1-03
HER2-Low to HER2-Ultralow: Redefining HER2-Targeted Therapy
Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, NY
Presentation numberED1-04
Immune Biomarkers Driving Immunotherapy Selection in Metastatic TNBC
Giampaolo Bianchini, IRCCS San Raffaele Hospital, MIlan, Italy
Presentation numberED1-05
Biomarkers for the WIN!
Kelly Shanahan, METAvivor Research and Support, South Lake Tahoe, CA